This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Combatting the pandemic has highlighted the importance of the partnership between biopharma organizations and the contractmanufacturing organizations (CMOs) that must flexibly handle outsourced production, which can come suddenly and often must quickly be ramped up.
The online marketplace PartnerSlate has made waves in the food and beverage contractmanufacturing industry, recently securing a $4 million investment to further its mission of connecting food brands and contractmanufacturers. This is where San Francisco-based PartnerSlate comes in.
The state plans to work directly with a contractmanufacturing organization (CMO) to manufacture low-cost insulin. The documents state that a partnership with a CMO would be cheaper than the state directly manufacturing insulin. This CMO will be responsible for product roll-out and distribution.
Pharma ContractManufacturing: From the pharmaceutical sector there is a group of businesses that have tasked themselves to assist other businesses to provide better solutions to customers. When a contractmanufacturing company wakes up with a customer in the business, the customer cannot control the jobs the CMO is in control of.
To get a pulse on Moderna following its “year of transition” in 2023, look no further than the company’s manufacturing operations. | To get a pulse on Moderna following its “year of transition” in 2023, look no further than the company’s manufacturing operations.
The success of COVID-19 vaccines paved the path for mRNA-based drug products. Safety, efficacy and rapid production of mRNA drives the interest in this domain. mRNA has completely revolutionized the field of medicine and significantly influenced the study and treatment of human diseases.
The global antibodies contractmanufacturing market is expected to reach from USD 13.4 Rise in demand for the production of therapeutic antibodies … Continue reading → billion in 2022 to USD 35.9 billion by 2030, registering a CAGR of 13.1% from 2022 to 2030.
Oncology products monopolise the list of best-selling drugs. Several oncology products now have “blockbuster” status where sales exceed $1 billion annually. This is relevant for clinical trials as more regulators require evidence of efficacy in comparison to the standard of care, which is likely to be one of the blockbuster products.
4th Edition Market Study into Small Molecule Drug ProductContractManufacturer Quality – ResearchAndMarkets.com 4th Edition Market Study into Small Molecule Drug ProductContractManufacturer Quality – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Small Molecule Drug ProductContractManufacturer Quality Benchmarking (..)
Under the agreement, Aurena Laboratories will establish a production unit to meet the regulatory requirements for the manufacture of Lipidor’s pharmaceutical products. This will enable Lipidor to offer potential licensees the opportunity for large-scale commercial production.
After charting multiple personalized medicine expansions in recent years, contractmanufacturer Charles River Laboratories is back with another gene therapy pact—this time centered on an adeno-asso | After charting multiple personalized medicine expansions in recent years, contractmanufacturer Charles River Laboratories is back with another gene therapy (..)
In this context, it is worth highlighting those 14 biopharmaceutical products ( including cell therapies, gene therapies, monoclonal antibodies and recombinant proteins ) were approved in the US alone, in 2021. As a result, biopharmaceutical contractmanufacturing has picked up pace in the recent years.
Requirement of higher biopharmaceutical manufacturing capacity products owing to the increasing demand for such drugs. Advanced and complex technologies are required for manufacturing, as well as testing of biopharmaceuticals.
In this context, it is worth highlighting those 14 biopharmaceutical products ( including cell therapies, gene therapies, monoclonal antibodies and recombinant proteins ) were approved in the US alone, in 2021. As a result, biopharmaceutical contractmanufacturing has picked up pace in the recent years.
Several months after Societal CDMO launched a restructuring campaign that led to 26 layoffs, the small molecule contractmanufacturer has announced it’s being bought by one of its production peers | Several months after Societal CDMO launched a restructuring campaign that led to 26 layoffs, the small molecule contractmanufacturer has announced it’s (..)
Symbiosis Pharmaceutical Services Ltd (Symbiosis), a fast-growing contractmanufacturing organisation (CMO) specialising in sterile global manufacture of pharmaceuticals, vaccines and biopharmaceuticals including Advanced Therapeutical Medicinal Products (ATMPs), has announced the completion of a £1.3
In the last year, well-known contractmanufacturing organisations (CMOs) such as Agilent Technologies (Santa Clara, California) and Abzena (Cambridge, UK) have expanded their continuous manufacturing capabilities. US Congress is also making substantial investments to improve the continuous manufacturing of pharmaceuticals.
WuXi Vaccines launched its first standalone vaccine contractmanufacturing facility in Suzhou. With the plant, the company adds drug substance and drug product capacity for projects in various stages of development.
Amid a corporate review of AstraZeneca’s global manufacturing and supply network, the company’s Indian subsidiary is planning to close up shop at the “beating heart” of its India operations in Bang | AstraZeneca Pharma India will exit its production plant in Bangalore, India, “in due course,” the company said in a filing.
The onset of the COVID-19 pandemic has contributed greatly to the increasing demand of oligonucleotide-based products, consequently, proposing lucrative opportunities for custom / contract service providers engaged in this domain. The overall manufacturing of oligonucleotides involves the following steps. Web: [link].
With over 18 years of experience, Alexander Dragitsch is a commercial customer service contractmanufacturing (CSCM) manager at Baxter’s Halle/Westfalen facility in Germany. Alex and his team have the significant responsibility of managing various commercial programs for more than 40 marketed products.
The current landscape consists of more than 95 players that claim to offer oligonucleotide contractmanufacturing services for research, diagnostic and therapeutic applications. These contract service providers are actively entering into strategic collaborations to augment their existing portfolios. Our Social Media Platform.
On the back of several strong quarters and a year already chock-full of manufacturing accords, Korean CDMO Samsung Biologics is adding yet another project to its contractmanufacturing Rolodex. Samsung Biologics said it inked a series of production pacts with an unnamed European pharma in a tie-up worth a total of $668 million.
Nearly a year after Coherus BioSciences’ on-body injector for Udenyca was rejected over external production issues, a third-party manufacturer has caused another spot of bother for the Ca | Thanks to “over-commitments and capacity constraints” facing the U.S.-based
Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Why do large and mega-cap sponsors outsource?
Catalent, one of the largest contractmanufacturers in the pharmaceutical industry, was cited by the U.S. Food and Drug Administration for a series of quality control failures at a facility in Bloomington, Ind., the same plant where the company helps produce two Covid-19 vaccines.
SUS provides full, free and universal access to healthcare for the country's entire population (215 million), which spends around 10% of its gross domestic product (GDP) on healthcare. Only a limited number of international pharma companies, however, operate manufacturing sites in the country.
These industries unexpectedly also included biotech, which was not a particularly strong area for Chinese manufacturing, which is more recognised for generics production. Guangdong is based in the south and has a comparatively strong number of manufacturing relationships producing innovative FDA and EMA drugs.
Adds 185,000 litres of biopharmaceutical production capacity High degree of digitalization and automation through smart technologies and artificial intelligence applications Multi-product setup enables production of a large variety of molecule formats Investment of more than 700 million EUR, creating 500 new jobs.
Streamlined development, flexibility in manufacturing, and improved product quality at reduced costs, while gaining access to capabilities and capacity are some of the factors fuelling the pharmaceutical solid dosage contractmanufacturing market.
Working with a contractmanufacturing organization (CMO) in the pursuit of bringing a new product to market can deliver a range of significant benefits. They are also likely to have already worked with a similar molecule and can even anticipate the hurdles a company may face in production. Proven results??.
Ozempic has been plagued by a shortage fueled by demand, and Wegovy has had contract-manufacturing-related supply chain issues, but that hasn’t prevented Novo’s GLP-1 franchise from achieving overall sales growth of 44% for the first nine months of the year.
The growing demand for innovative drugs and a limited number of blockbuster drugs has led to the growth of the pharmaceutical contractmanufacturing market, which has fuelled contract commercial dose manufacturing and marketing. Contract marketing of commercial doses.
As such there are several factors which will continue to drive radiopharmaceutical production market. Radiopharmaceutical Production Market The production of radiopharmaceuticals typically requires a specific set of components, including a radionuclide generator and a radiopharmaceutical precursor.
Douglas Pharmaceuticals overview Douglas Pharmaceuticals (Douglas) carries out the development and manufacture of nutraceutical and health products. The company offers consumer, prescription and automation products. Its investigational medicinal products comprise R-107, R-131 and R-147.
Douglas Pharmaceuticals overview Douglas Pharmaceuticals (Douglas) carries out the development and manufacture of nutraceutical and health products. The company offers consumer, prescription and automation products. Its investigational medicinal products comprise R-107, R-131 and R-147.
According to GlobalData analysis, specialist small molecule API capabilities such as containment or controlled substances are driving large contractmanufacturing organisations (CMOs) to acquire facilities. Download the whitepaper below to find out more about ILC Dover’s flexible solutions for protecting the entire supply chain.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content